U.S. - Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingHuman And Animal Blood Prices in the United States
U.S. Human And Animal Blood Export Price per Ton in May 2022
In May 2022, the human and animal blood price per ton amounted to $208.3K (FOB, US), rising by 2% against the previous month. Overall, export price indicated moderate growth from January 2022 to May 2022: its price increased at an average monthly rate of +3.6% over the last four-month period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on May 2022 figures, human and animal blood export price increased by +73.3% against March 2022 indices. The pace of growth appeared the most rapid in April 2022 an increase of 70% month-to-month. The export price peaked in May 2022.
There were significant differences in the average prices for the major external markets. In May 2022, the country with the highest price was China ($305.5K per ton), while the average price for exports to Mexico ($25.7K per ton) was amongst the lowest.
From January 2022 to May 2022, the most notable rate of growth in terms of prices was recorded for supplies to France (+55.4%), while the prices for the other major destinations experienced more modest paces of growth.
U.S. Human And Animal Blood Exports
In June 2022, shipments abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by -11.4% to 636 tons, falling for the third month in a row after three months of growth. In general, exports faced a abrupt decrease. The growth pace was the most rapid in March 2022 with an increase of 27% against the previous month. As a result, the exports attained the peak of 2K tons. From April 2022 to June 2022, the growth of the exports remained at a lower figure.
In value terms, human and animal blood exports fell sharply to $102M (IndexBox estimates) in June 2022. Overall, exports recorded a abrupt decrease. The pace of growth appeared the most rapid in February 2022 with an increase of 12% against the previous month. As a result, the exports attained the peak of $260M. From March 2022 to June 2022, the growth of the exports failed to regain momentum.
U.S. Human And Animal Blood Exports by Country
Canada (192 tons), Brazil (97 tons) and the UK (91 tons) were the main destinations of human and animal blood exports from the United States, together comprising 53% of total exports. These countries were followed by Mexico, China, Japan, the Netherlands, Ecuador, Vietnam, Germany, Taiwan (Chinese), Thailand and France, which together accounted for a further 38%.
From January 2022 to May 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Vietnam (with a CAGR of +130.2%), while the other leaders experienced more modest paces of growth.
In value terms, China ($14M), the UK ($14M) and Brazil ($10M) constituted the largest markets for human and animal blood exported from the United States worldwide, with a combined 26% share of total exports. These countries were followed by Canada, Japan, the Netherlands, Germany, Vietnam, Mexico, France, Ecuador, Thailand and Taiwan (Chinese), which together accounted for a further 18%.
In terms of the main countries of destination, Vietnam, with a CAGR of +121.1%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
This report provides an in-depth analysis of the market for human and animal blood in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2024
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2024
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Per Capita Consumption In 2012-2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
- Trade Balance, In Physical Terms, 2012-2024
- Trade Balance, In Value Terms, 2012-2024
- Per Capita Consumption, 2012-2024
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2024
- Production, In Value Terms, 2012–2024
- Imports, In Physical Terms, 2012–2024
- Imports, In Value Terms, 2012–2024
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, 2012–2024
- Exports, In Value Terms, 2012–2024
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
387
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
435
This report provides an in-depth analysis of the antisera market in the U.S..
530
This report provides an in-depth analysis of the biological product market in the U.S..
462
This report provides an in-depth analysis of the vaccine market in the U.S..
328
This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S..
492
This report provides an in-depth analysis of the global market for human and animal blood.
1980
This report provides an in-depth analysis of the global antisera market.
424
This report provides an in-depth analysis of the global biological product market.
2589
This report provides an in-depth analysis of the global vaccine market.
641
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
65
In the period of 2018 to 2024, the growth of exports for Human And Animal Blood failed to regain momentum. The value of exports declined to $3.5B in 2024.
1356
From February 2023 to December 2023, the exports of Human And Animal Blood saw a significant decline, dropping to $71M in value.
113
Haleon invests $54M in its U.S. R&D centre to drive innovation in consumer healthcare, enhancing its product pipeline and maintaining competitive edge.
596
For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by...
113
U.S. experts predict a smaller winter COVID wave, posing challenges for Pfizer amid declining revenues, emphasizing the need to diversify non-COVID products.
241
Explore Moderna's ongoing phase three norovirus vaccine trial targeting urgent prevention needs amid rising outbreaks in the U.S.
208
Moderna has secured $590 million to enhance pandemic influenza vaccine development, focusing on mRNA technology and expanding human trials.
92
Moderna's shares increased by over 10% due to progress in H5N1 vaccine development following a human fatality in the U.S.
905
Explore the top import markets for human and animal blood and their key statistics. Find out which countries are leading in the import of blood products.
81
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
